High ‐flow nasal cannula oxygen therapy for the treatment of acute respiratory failure secondary to SARS‐CoV‐2 pneumonia out of ICU

ConclusionsHFNC outside an ICU is a treatment with high success rate in patients with AHRF secondary to SARS-CoV-2 pneumonia, including in patients in whom this therapy was deemed to be the ceiling of treatment.

Source: The Clinical Respiratory Journal - August 4, 2023 Category: Respiratory Medicine Authors: Sonia Castro, Sandra Pedrero, Luis Alberto Ruiz, Leyre Serrano, Rafael Zalacain, Silvia P érez‐Fernández, Milagros Iriberri, Valentín Cabriada Tags: ORIGINAL ARTICLE Source Type: research